The abortion pill mifepristone "is not safe and effective," argue the authors of a new study that uses insurance claim data to examine adverse reactions to the pill. They claim to have found a ...
Hosted on MSN
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The trial results are among the pharmaceutical ...
Some analysts say Eli Lilly's daily obesity pill, if approved, could still be a viable competitor in the weight loss drug market despite late-stage trial data that disappointed investors. In the trial ...
The number of abortions in the U.S. rose again in 2024, with women continuing to find ways to get them despite bans and restrictions in many states, according to a report out Monday. The latest report ...
Shares of Viking Therapeutics VKTX plunged 42% yesterday after it reported top-line data from the phase II VENTURE-Oral Dosing study, which evaluated the safety and efficacy of the oral formulation of ...
Add Yahoo as a preferred source to see more of our stories on Google. Sue Dorfman/ZUMAPRESS/Newscom The abortion pill mifepristone "is not safe and effective," argue the authors of a new study that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results